LAUREN SCHEFFY: Open Payments
NPI 1154349694 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 34 payments from 10 companies in 2025. Trend: 2023 $915 · 2024 $876 · 2025 $770
Food & beverage: $595Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $384 |
| Axsome Therapeutics, Inc. | 4 | $82 |
| Lundbeck LLC | 3 | $62 |
| Antares Pharma, Inc. | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Ardelyx, Inc. | 2 | $43 |
| Exact Sciences Corporation | 2 | $32 |
| Recor Medical Inc | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $15 |
Products named: PROLIA, EVENITY, OTEZLA, Auvelity, XYOSTED, REXULTI, CAPLYTA, IBSRELA.
Industry payments across LA — which companies pay providers there.
